Omar H. Khalil manages Santé’s Boston Office and concentrates on biotechnology, where he partners with scientific founders and entrepreneurs across multiple therapeutic areas and modalities. Omar joined Santé in 2007 and rejoined in 2020 after holding various transactional and operational leadership roles within the pharmaceutical and biotech industry. He held senior leadership roles with Baxter International, Baxalta (now part of Takeda), and Kaléo, a commercial-stage biotech company. In these positions, he led and managed businesses ranging from early clinical development to commercial launch, which scaled to more than $3 Billion in annual sales. Earlier in his career, he worked at McKinsey & Company in the healthcare practice, advising leading pharmaceutical and medical device companies on growth and M&A strategies. Omar serves as a board member, advisor, and mentor to several organizations focused on biotech entrepreneurship and is a member of the Leadership Advisory Board at the University of Michigan College of Engineering. He received his MSE and BSE in Biomedical Engineering summa cum laude from the University of Michigan with a concentration in Tissue Engineering.